The CTC diagnostics market is predicted to surpass the valuation of about US$ 9.5 billion by 2030. Circulating tumour cells (CTCs) are a prominent topic in oncological research and conferences due to their huge potential for both cancer diagnosis and treatment.
The report highlights the potential of CTC enrichment technology for CTC diagnostics and is upbeat about the financial performance of investments made in this area. The promise of CTC diagnostics extends beyond just identifying cancers; it also goes beyond that to offer assistance in gathering the necessary information. The importance of Circulating Tumour Cells (CTC) Diagnostics in Cancer Therapies and Treatment is anticipated to Remain Significant in the Future
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5510
Major Stakeholders
- Qiagen
- Bio-Techne Corporation
- Janssen Diagnostics LLC
- Advanced cell Diagnostics Inc
- ApoCell Inc
- Celltraffix Inc.
- Aviva Biosciences
- Biocept Inc
- Clearbridge Biomedics
- Fluxion Biosciences
- IVDiagnostics
- Stemcell Technologies Inc
- Stemcell Technologies Inc.
- Sysmex Corporation. Leading
Salient Points
- The CTC diagnostics market has surpassed the mark of US$ 6 billion, as it reached the valuation of US$ 6.3 billion in 2020. The primary factor to drive the market remains the ongoing research in the field of cancer diagnostics and alarmingly increasing number of cancer deaths around the world.
- The market is expected to witness exponential growth in the coming decade as the projected CAGR is likely to exceed beyond 17% during the forecast period of 2020 to 2030.
- The adoption of CTC enrichment methods is likely to remain significantly high, as the segment is projected to reach the valuation of over US$ 9.5 billion by the end of the assessment period.
- The North American market for CTC diagnostics is expected to lead the regional category with a valuation of over US$ 2 billion in 2020. With the ongoing cancer research in the region and growing presence of market leaders, the regional market is expected to secure one-third revenue share in the global space.
- Patients’ inclination towards non-invasive diagnostics tests and prognostic tools for predicting or detecting the risks of cancer is one of the driving forces for the growth of the market. Manufacturers are also expected to experiment around technologies for detection and analyzing CTCs to improve accuracy and reliability of results.
Market Structure
The study offers a detailed estimation and outlook of the CTC diagnostics market based on the product, technology, application, sample type, and region.
Product
- Devices & Systems
- Kits & Reagents
- Other Consumables
Technology
- CTC Enrichment Methods
- CTC Detection Methods
- CTC Analysis
Application
- Cancer Stem Cell Research
- EMT Biomarkers Development
- Tumorigenesis Research
- Others
Sample Type
- Blood
- Bone Marrow
- Others
Predominant Questions Answered in This Report Are:
- Which segments will perform well in the CTC diagnostics Market over the forecasted years?
- In which markets companies should authorize their presence?
- What are the forecasted growth rates for the CTC diagnostics Market?
- What are the long-lasting defects of the industry?
- How share market changes their values by different manufacturing brands?
- What are the qualities and shortcomings of the key players?
- What are the major end results and effects of the five strengths study of industry?
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5510
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : [email protected]